Project dates: September 2012 – September 2016
Archive | AngolaRSS feed for this section
SIAPS’ role to control malaria was recently featured in Health & Humanitarian: The Supply Chain Review. Between 2000 and 2015, malaria case incidences declined by 41% and mortality rates by 62%. However, approximately 212 million people were infected and 429,000 people died in 2015, with the majority being children under the age of 5 in […]
SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.
Defeating malaria through pharmaceutical systems strengthening: A review of SIAPS’s activities in eight countries
SIAPS recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria. This report summarizes systems strengthening interventions that support the prevention and treatment of malaria. With funding from the US President’s Malaria Initiative (PMI) and based […]
By Wonder Goredema, Senior Technical Advisor and SIAPS Technical Support Lead/ Acting Country Project Director – Angola On September 27, 2016, Dra. Katiza Mangueira, the Head of the Angola Ministry of Health’s Directorate of Medicines and Equipment (Direcção Nacional de Medicamentos e Equipamentos [DNME]) accepted three desktop computers and power surge adaptors from the Angola […]
The DNME of the MINSA recognizes the importance of regulating pharmaceutical products and wants to introduce a new policy to mandate product registration to better control the safety, quality, and efficacy of pharmaceutical products. The National Department of Medicine and Health Products of the DNME is the responsible unit for managing pharmaceutical product registration. However, the unit has been challenged by a lack of staff and budget when preparing to implement this new policy.
The DNME has been preparing to implement a new policy that will switch from importer-based regulations to product-based regulations. However, has been challenging to build a comprehensive database on the importation and distribution of pharmaceutical products that could be used to understand the quantities and types of medicines that need to be registered.
In 2012, the US Agency for International Development-funded SIAPS Program conducted a comprehensive assessment of the current regulatory system in Angola and the DNME’s capacity to strengthen that system. As a follow-up, in April 2015 and 2016, SIAPS was invited by the DNME to provide technical assistance to prepare a new policy that would mandate product registration by assessing the current situation and developing implementation strategies for the new policy.
By Stacy Lu, SIAPS Technical Writer Based on USAID/Angola’s Gindungo Newsletter by Paul McDermott, Acting USAID/Angola Mission Director, and Gastao Figueiredo, Editor The Angolan Central Procurement Agency for Medicines and Medical Supplies (CECOMA) has developed a draft strategy to reform and strengthen the country’s pharmaceuticals system. CECOMA developed the strategy during a hree-day workshop in June […]
SIAPS Supports Angola Ministry of Health to Develop First Ever National Supply Chain Strategy for Health Commodities
Angola’s National Plan for Health 2012-2025 (Plano Nacional de Decenvolvimento Sanil – PNDS 2012-2025) has highlighted the lack of a comprehensive and strategic supply chain plan as a key challenge to access pharmaceuticals in Angola. Ministry of Health (MOH) key players and local supply chain stakeholders have since called for the development of a national […]
Technical Highlight: Design, Implementation, and Use of Pharmaceutical Logistics Management Information Systems (LMIS)
This technical highlight describes promising practices in assessing, designing, and implementing a LMIS based on SIAPS Program’s experience. The promising practices are supported by case examples of LMIS implementation from Bangladesh, Swaziland, and West Africa.
Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update – January—March 2016
Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI- focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.
The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.
This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between January and March 2016.
- Using Support Supervisory Visits for Monitoring and Mentorship for Pharmaceutical Services Delivery in Namibia
SIAPS has supported the Division: Pharmaceutical Services to conduct support supervisory visit (SSVs) to monitor and assess progress of the […]
SIAPS helped improve pharmaceutical product quality by building the capacity of the Namibia Medicines Regulatory Council (NMRC) to review medicine […]
The purpose, objectives, and activities of this program are designed to reflect the Government of Sierra Leone’s Health Sector Recovery […]